DexCom Inc (DXCM)

77.75
0.42 0.54
NASDAQ : Health Care
Prev Close 77.33
Open 77.60
Day Low/High 75.91 / 78.15
52 Wk Low/High 47.92 / 103.29
Volume 859.64K
Avg Volume 1.08M
Exchange NASDAQ
Shares Outstanding 86.37M
Market Cap 6.68B
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

New Study Shows Adults With Type 1 And Type 2 Diabetes On Multiple Daily Injections (MDI) Benefit From CGM

DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, is presenting important clinical data for patients with type 1 and type 2 diabetes, at the American Diabetes...

Dexcom To Add Ambulatory Glucose Profile (AGP) To Dexcom CLARITY®

DexCom, Inc. (NASDAQ: DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that it incorporated Ambulatory Glucose Profile (AGP) into its Dexcom CLARITY software.

DexCom Shares Rise After FDA Approves G5 Mobile App for Android Devices

DexCom Shares Rise After FDA Approves G5 Mobile App for Android Devices

DexCom's app tracks glucose levels for people with diabetes.

DexCom Announces FDA Approval Of G5 Mobile App For Android Devices

DexCom, Inc. (Nasdaq: DXCM) the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce the Food and Drug Administration (FDA) approval of the Dexcom G5 mobile app for Android...

Apple Watch Appears on Its Way to Becoming a $6 Billion Business

Apple Watch Appears on Its Way to Becoming a $6 Billion Business

After a slump early last year, the smartwatch's sales have been rebounding. New features unveiled at Apple's WWDC conference could aid its momentum later this year.

DexCom Stock Surging on Apple Watch Partnership

DexCom Stock Surging on Apple Watch Partnership

Apple will release a new Bluetooth API for the Apple Watch.

Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)

Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)

First serious down day in ages? Jim Cramer says it's as normal as rain; and he has an umbrella for you.

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Kevin Sayer, President & Chief Executive Officer, will present on...

DexCom Prices Offering Of $350 Million Of 0.75% Convertible Senior Notes

DexCom, Inc. (Nasdaq: DXCM) ("DexCom") announced today the pricing of its offering of $350 million aggregate principal amount of 0.

DexCom Announces Proposed Offering Of $300 Million Of Convertible Senior Notes

DexCom, Inc. (Nasdaq: DXCM) ("DexCom") announced today that it intends to offer, subject to market conditions and other factors, $300 million aggregate principal amount of Convertible Senior Notes due 2022 (the "notes") in...

DexCom, Inc. Reports First Quarter 2017 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended March 31, 2017.

10 Things We Learned From Our Daily Facebook Show With Jim Cramer

10 Things We Learned From Our Daily Facebook Show With Jim Cramer

A few important takeaways from our daily Facebook show with Jim Cramer.

Jim Cramer: Report of Apple's Diabetes Test Isn't a Reason to Own the Stock

Jim Cramer: Report of Apple's Diabetes Test Isn't a Reason to Own the Stock

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said reports of Apple developing a diabetes testing product is not a reason to own the stock.

Trader's Daily Notebook: Worried About Volume? Just Let It Go

Trader's Daily Notebook: Worried About Volume? Just Let It Go

Old-line momentum favorites fare well.

Trader's Daily Notebook: Worried About Volume? Just Let It Go

Trader's Daily Notebook: Worried About Volume? Just Let It Go

Old-line momentum favorites fare well.

Medicare Announces Criteria Covering Dexcom G5 Mobile CGM For All People With Diabetes On Intensive Insulin Therapy

DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce that the U.

DexCom Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2017 financial results after market close on Tuesday, May 2, 2017.

When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17)

When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17)

Jim Cramer says economic fundamentals remain strong and this market's rallying with relief at Fed's anticipated rate hike.

DexCom Appoints Richard Collins To Board Of Directors

DexCom, Inc. (Nasdaq: DXCM) today announced that Richard Collins has been appointed to the company's Board of Directors, effective March 9, 2017.

DexCom, Inc. Reports Fourth Quarter And Fiscal Year 2016 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2016.

DexCom Announces Upcoming Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: Steven Pacelli, Executive Vice President, Strategy and Corporate...

DexCom Is a Great Healthcare Stock to Buy Now

DexCom Is a Great Healthcare Stock to Buy Now

The continuous glucose monitor maker is an excellent growth opportunity.

Alphabet's Verily Sells Stake to Temasek in Bid for Overseas Expansion

Alphabet's Verily Sells Stake to Temasek in Bid for Overseas Expansion

The sale of the $800M stake to Temasek comes as the Google parent scales back some of its other big bets.

DexCom Schedules Fourth Quarter And Full Year 2016 Earnings Release And Conference Call For February 28, 2017 At 4:30 P.m. Eastern Time

DexCom Schedules Fourth Quarter And Full Year 2016 Earnings Release And Conference Call For February 28, 2017 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2016 financial results after market close on Tuesday, February 28, 2017.

The Pain Before the Gains: Cramer's 'Mad Money' Recap (Thursday 1/19/17)

The Pain Before the Gains: Cramer's 'Mad Money' Recap (Thursday 1/19/17)

Don't worry about a little selloff, says Jim Cramer. The data and earnings signal an improving economy.

Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns

Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns

These companies show signs of a change of direction.

Earnings Key to Next Week's Winners: Cramer's 'Mad Money' Recap (Friday 1/13/17)

Earnings Key to Next Week's Winners: Cramer's 'Mad Money' Recap (Friday 1/13/17)

Jim Cramer highlights bank, health-care companies reporting next week and what to watch.